You are here
,

Novartis, Amgen in dispute over migraine drug partnership

  • Saturday 6 April 2019
  • Posted by Aftab Ahmad
  • 0 Comments
Swiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotechnology company of trying to wrongfully back out of agreements to jointly develop and market the migraine prevention drug Aimovig and keep the profits for itself.


from Reuters: Health News https://reut.rs/2Vpl0So

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply